Danish
Novo resubmits FDA application for two diabetes drugs
March 27, 2015Sales and Marketing Danish, FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes
Novo Nordisk will re-submit an FDA application for its diabetes drugs Tresiba and Ryzodeg two years after their initial rejection …
Novo Nordisk scraps inflammatory disorders business
September 2, 2014Research and Development, Sales and Marketing Danish, IL20, Novo Nordisk, diabetes, inflammatory, thomsen
A restructuring of Novo Nordisk will see it completely drop its inflammatory disorders activities in favour of concentrating on its …
Danish government: ‘Sue pharma firms’
January 23, 2014Sales and Marketing Actavis, Danish, Denmark, Lundbeck, celexa
A senior figure in Denmark’s government has said that local authorities should take legal action against pharma firms which put …
Lexapro US loss hits Lundbeck
February 7, 2013Sales and Marketing Danish, Lexapro, Lundbeck
The loss of US patent protection on antidepressant Lexapro has put a significant dent in Lundbeck’s financial performance for 2012. …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
